a developer of novel antibody therapeutics for oncology targets
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VLIFX | 35.83 | 0.10 | +0.28% |
Value Line Mid Cap Focused | |||
DEVDX | 12.88 | N/A | N/A |
Driehaus Event Driven | |||
HWAIX | 41.15 | -0.01 | -0.02% |
Hotchkis & Wiley Value Opps Instl | |||
NBPIX | 46.88 | -0.15 | -0.32% |
Neuberger Berman Large Cap Value Instl | |||
HIOIX | 12.15 | -0.05 | -0.41% |
Fintrust Income and Opportunity Instl |
A.I.dvisor indicates that over the last year, YMAB has been loosely correlated with RCKT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if YMAB jumps, then RCKT could also see price increases.
Ticker / NAME | Correlation To YMAB | 1D Price Change % | ||
---|---|---|---|---|
YMAB | 100% | +0.88% | ||
RCKT - YMAB | 38% Loosely correlated | -0.91% | ||
IDYA - YMAB | 38% Loosely correlated | +4.90% | ||
PGEN - YMAB | 36% Loosely correlated | -0.49% | ||
FATE - YMAB | 36% Loosely correlated | +13.58% | ||
NKTX - YMAB | 35% Loosely correlated | +1.25% | ||
More |